comparemela.com
  1. Home
  2. Live Updates
  3. Ep 03 - Breaking News

Ep 03 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tarsus: TP-03 Phase 2a Clinical Trial Shows Positive Data In MGD In Patients With Demodex Mites

Tarsus Pharmaceuticals, Inc. (TARS) announced Monday positive topline results from the Ersa Phase 2a clinical trial evaluating TP-03 (lotilaner ophthalmic solution, 0.

Bobak azamianTarsus pharmaceuticals incDrug administrationMore such health newsTarsus pharmaceuticalsErsa phaseMeibomian gland diseaseMeibomian gland secretion scoreChief executive officerEp 03Eibomian gland diseaseDemodex mites

Podcast: Business Class- S01- EP-03

What is alternative financing? What are some of the international best practices? How can Omani ecosystem build a better alternative financing.

Riza ismailKhalid al huraibiBusiness classEp 03

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.